Barriers to Gene Delivery Using Synthetic Vectors

Advances in Genetics

Volumn 53, Issue , 2005, Pages 19-46

  Read, Martin L ^a   Logan, Ann ^a   Seymour, Leonard W ^b  

^a Wolfson Research Laboratories   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYAMINE; POLYCATIONS;

ACTIVE TRANSPORT; CIRCULATION TIME; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVIEW; TRANSPORT VESICLE;

ACTIVE TRANSPORT, CELL NUCLEUS; BLOOD CIRCULATION TIME; GENE TARGETING; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; POLYAMINES; TRANSPORT VESICLES;

EID: 27244457081     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2660(05)53002-5     Document Type: Review

References (81)

1. Adami R.C., and Rice K.G. Metabolic stability of glutaraldehyde cross-linked peptide DNA condensates. J. Pharm. Sci. 88 (1999) 739-746
2. Aoki K., Furuhata S., Hatanaka K., Maeda M., Remy J.S., Behr J.P., Terada M., and Yoshida T. Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity. Gene. Ther. 8 (2001) 508-514
3. Bettinger T., Carlisle R.C., Read M.L., Ogris M., and Seymour L.W. Peptide-mediated RNA delivery: A novel approach for enhanced transfection of primary and post-mitotic cells. Nucleic Acids Res. 29 (2001) 3882-3891
4. Bettinger T., and Read M.L. Recent developments in RNA-based strategies for cancer gene therapy. Curr. Opin. Mol. Ther. 3 (2001) 116-124
5. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92 (1995) 7297-7301
6. Branden L.J., Mohamed A.J., and Smith C.I. A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. Nat. Biotechnol. 17 (1999) 784-787
7. Bremner K.H., Seymour L.W., Logan A., and Read M.L. Factors influencing the ability of nuclear localization sequence peptides to enhance non-viral gene delivery. Bioconjug. Chem. 15 (2004) 152-161
8. Bremner K.H., Seymour L.W., and Pouton C.W. Harnessing nuclear localization pathways for transgene delivery. Curr. Opin. Mol. Ther. 3 (2001) 170-177
9. Brunner S., Sauer T., Carotta S., Cotten M., Saltik M., and Wagner E. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene. Ther. 7 (2000) 401-407
10. Ciolina C., Byk G., Blanche F., Thuillier V., Scherman D., and Wils P. Coupling of nuclear localization signals to plasmid DNA and specific interaction of the conjugates with importin alpha. Bioconjug. Chem. 10 (1999) 49-55
11. Coll J.L., Chollet P., Brambilla E., Desplanques D., Behr J.P., and Favrot M. In vivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum. Gene. Ther. 10 (1999) 1659-1666
12. Cotten M., Langle-Rouault F., Kirlappos H., Wagner E., Mechtler K., Zenke M., Beug H., and Birnstiel M.L. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc. Natl. Acad. Sci. USA 87 (1990) 4033-4037
13. Cullis P.R., Chonn A., and Semple S.C. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. Adv. Drug. Deliv. Rev. 32 (1998) 3-17
14. Dash P.R., Read M.L., Barrett L.B., Wolfert M.A., and Seymour L.W. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene. Ther. 6 (1999) 643-650
15. Dash P.R., Read M.L., Fisher K.D., Howard K.A., Wolfert M., Oupicky D., Subr V., Strohalm J., Ulbrich K., and Seymour L.W. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J. Biol. Chem. 275 (2000) 3793-3802
16. Dash P.R., Toncheva V., Schacht E., and Seymour L.W. Synthetic polymers for vectorial delivery of DNA: Characterisation of polymer-DNA complexes by photon correlation spectroscopy and stability to nuclease degradation and disruption by polyanions in vitro. J. Control Release 48 (1997) 269-276
17. Davis S.S., Hunneyball I.M., Illum L., Ratcliffe J.H., Smith A., and Wilson C.G. Recent advances in the use of microspheres for targeted therapy. Drugs Exp. Clin. Res. 11 (1985) 633-640
18. Dorsett Y., and Tuschl T. siRNAs: Applications in functional genomics and potential as therapeutics. Nat. Rev. Drug. Discov. 3 (2004) 318-329
19. Erbacher P., Roche A.C., Monsigny M., and Midoux P. Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes. Exp. Cell. Res. 225 (1996) 186-194
20. Fisher K.D., Ulbrich K., Subr V., Ward C.M., Mautner V., Blakey D., and Seymour L.W. A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene. Ther. 7 (2000) 1337-1343
21. Forrest M.L., and Pack D.W. On the kinetics of polyplex endocytic trafficking: Implications for gene delivery vector design. Mol. Ther. 6 (2002) 57-66
22. Gabizon A., Shmeeda H., and Barenholz Y. Pharmacokinetics of pegylated liposomal Doxorubicin: Review of animal and human studies. Clin. Pharmacokinet. 42 (2003) 419-436
23. Godbey W.T., Wu K.K., and Mikos A.G. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. USA 96 (1999) 5177-5181
24. Gonçalves C., Pichon C., Guerin B., and Midoux P. Intracellular processing and stability of DNA complexed with histidylated polylysine conjugates. J. Gene. Med. 4 (2002) 271-281
25. Gregorevic P., Blankinship M.J., Allen J.M., Crawford R.W., Meuse L., Miller D.G., Russell D.W., and Chamberlain J.S. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat. Med. 10 (2004) 828-834
26. Hortobagyi G.N., Ueno N.T., Xia W., Zhang S., Wolf J.K., Putnam J.B., Weiden P.L., Willey J.S., Carey M., Branham D.L., Payne J.Y., Tucker S.D., Bartholomeusz C., Kilbourn R.G., De Jager R.L., Sneige N., Katz R.L., Anklesaria P., Ibrahim N.K., Murray J.L., Theriault R.L., Valero V., Gershenson D.M., Bevers M.W., Huang L., Lopez-Berestein G., and Hung M.C. Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: A phase I clinical trial. J. Clin. Oncol. 19 (2001) 3422-3433
27. Itaka K., Harada A., Yamasaki Y., Nakamura K., Kawaguchi H., and Kataoka K. In situ single cell observation by fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J. Gene. Med. 6 (2004) 76-84
28. Kichler A., Leborgne C., Coeytaux E., and Danos O. Polyethylenimine-mediated gene delivery: A mechanistic study. J. Gene. Med. 3 (2001) 135-144
29. Kircheis R., Ostermann E., Wolschek M.F., Lichtenberger C., Magin-Lachmann C., Wightman L., Kursa M., and Wagner E. Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity. Cancer Gene. Ther. 9 (2002) 673-680
30. Lanford R.E., Kanda P., and Kennedy R.C. Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell 46 (1986) 575-582
31. Lechardeur D., Sohn K.J., Haardt M., Joshi P.B., Monck M., Graham R.W., Beatty B., Squire J., O'Brodovich H., and Lukacs G.L. Metabolic instability of plasmid DNA in the cytosol: A potential barrier to gene transfer. Gene. Ther. 6 (1999) 482-497
32. Ludtke J.J., Zhang G., Sebestyen M.G., and Wolff J.A. A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. J. Cell Sci. 112 Pt. 12 (1999) 2033-2041
33. Maeda H., Seymour L.W., and Miyamoto Y. Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo. Bioconjug. Chem. 3 (1992) 351-362
34. Maruyama H., Higuchi N., Nishikawa Y., Kameda S., Iino N., Kazama J.J., Takahashi N., Sugawa M., Hanawa H., Tada N., Miyazaki J., and Gejyo F. High-level expression of naked DNA delivered to rat liver via tail vein injection. J. Gene. Med. 4 (2002) 333-341
35. Matsumura Y., and Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46 (1986) 6387-6392
36. Maul G.G., and Deaven L. Quantitative determination of nuclear pore complexes in cycling cells with differing DNA content. J. Cell Biol. 73 (1977) 748-760
37. McKenzie D.L., Kwok K.Y., and Rice K.G. A potent new class of reductively activated peptide gene delivery agents. J. Biol. Chem. 275 (2000) 9970-9977
38. Monck M.A., Mori A., Lee D., Tam P., Wheeler J.J., Cullis P.R., and Scherrer P. Stabilized plasmid-lipid particles: Pharmacokinetics and plasmid delivery to distal tumors following intravenous injection. J. Drug. Target. 7 (2000) 439-452
39. Niedzinski E.J., Chen Y.J., Olson D.C., Parker E.A., Park H., Udove J.A., Scollay R., McMahon B.M., and Bennett M.J. Enhanced systemic transgene expression after noniviral salivary gland transfection using a novel endonuclease inhibitor/DNA formulation. Gene. Ther. 10 (2003) 2133-2138
40. Nielsen P.E., Egholm M., Berg R.H., and Buchardt O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254 (1991) 1497-1500
41. Oupicky D., Carlisle R.C., and Seymour L.W. Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo. Gene. Ther. 8 (2001) 713-724
42. Oupicky D., Howard K.A., Konak C., Dash P.R., Ulbrich K., and Seymour L.W. Steric stabilization of poly-L-Lysine/DNA complexes by the covalent attachment of semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]. Bioconjug. Chem. 11 (2000) 492-501
43. Oupicky D., Konak C., Dash P.R., Seymour L.W., and Ulbrich K. Effect of albumin and polyanion on the structure of DNA complexes with polycation containing hydrophilic nonionic block. Bioconjug. Chem. 10 (1999) 764-772
44. Oupicky D., Konak C., and Ulbrich K. DNA complexes with block and graft copolymers of N-(2-hydroxypropyl)methacrylamide and 2-(trimethylammonio)ethyl methacrylate. J. Biomater. Sci. Polym. Ed. 10 (1999) 573-590
45. Oupicky D., Ogris M., Howard K.A., Dash P.R., Ulbrich K., and Seymour L.W. Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol. Ther. 5 (2002) 463-472
46. Oupicky D., Ogris M., and Seymour L.W. Development of long-circulating polyelectrolyte complexes for systemic delivery of genes. J. Drug. Target. 10 (2002) 93-98
47. Oupicky D., Parker A.L., and Seymour L.W. Laterally stabilized complexes of DNA with linear reducible polycations: Strategy for triggered intracellular activation of DNA delivery vectors. J. Am. Chem. Soc. 124 (2002) 8-9
48. Pichon C., Goncalves C., and Midoux P. Histidine-rich peptides and polymers for nucleic acids delivery. Adv. Drug. Deliv. Rev. 53 (2001) 75-94
49. Pollard H., Remy J.S., Loussouarn G., Demolombe S., Behr J.P., and Escande D. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem. 273 (1998) 7507-7511
50. Pollard H., Toumaniantz G., Amos J.L., Avet-Loiseau H., Guihard G., Behr J.P., and Escande D. Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids. J. Gene. Med. 3 (2001) 153-164
51. Read M.L., Bremner K.H., Oupicky D., Green N.K., Searle P.F., and Seymour L.W. Vectors based on reducible polycations facilitate intracellular release of nucleic acids. J. Gene. Med. 5 (2003) 232-245
52. Read M.L., Singh S., Ahmed Z., Stevenson M., Briggs S.S., Oupicky D., Barrett L.B., Tirlapur U., Berry M., Preece J.A., Logan A., and Seymour L.W. A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acid (2005) (submitted).
53. Ross G.F., Bruno M.D., Uyeda M., Suzuki K., Nagao K., Whitsett J.A., and Korfhagen T.R. Enhanced reporter gene expression in cells transfected in the presence of DMI-2, an acid nuclease inhibitor. Gene. Ther. 5 (1998) 1244-1250
54. Schaffer D.V., Fidelman N.A., Dan N., and Lauffenburger D.A. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol. Bioeng. 67 (2000) 598-606
55. Sebestyen M.G., Ludtke J.J., Bassik M.C., Zhang G., Budker V., Lukhtanov E.A., Hagstrom J.E., and Wolff J.A. DNA vector chemistry: The covalent attachment of signal peptides to plasmid DNA. Nat. Biotechnol. 16 (1998) 80-85
56. Seymour L.W. Passive tumor targeting of soluble macromolecules and drug conjugates. Crit. Rev. Ther. Drug. Carrier. Syst. 9 (1992) 135-187
57. Seymour L.W., Miyamoto Y., Maeda H., Brereton M., Strohalm J., Ulbrich K., and Duncan R. Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. Eur. J. Cancer 31A (1995) 766-770
58. Sperinde J.J., Choi S.J., and Szoka Jr. F.C. Phage display selection of a peptide DNase II inhibitor that enhances gene delivery. J. Gene. Med. 3 (2001) 101-108
59. Stopeck A.T., Jones A., Hersh E.M., Thompson J.A., Finucane D.M., Gutheil J.C., and Gonzalez R. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma. Clin. Cancer. Res. 7 (2001) 2285-2291
60. Tam P., Monck M., Lee D., Ludkovski O., Leng E.C., Clow K., Stark H., Scherrer P., Graham R.W., and Cullis P.R. Stabilized plasmid-lipid particles for systemic gene therapy. Gene. Ther. 7 (2000) 1867-1874
61. Terebesi J., Kwok K.Y., and Rice K.G. Iodinated plasmid DNA as a tool for studying gene delivery. Anal. Biochem. 263 (1998) 120-123
62. Tokuda Y., Watanabe T., Omuro Y., Ando M., Katsumata N., Okumura A., Ohta M., Fujii H., Sasaki Y., Niwa T., and Tajima T. Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. Br. J. Cancer 81 (1999) 1419-1425
63. Toncheva V., Wolfert M.A., Dash P.R., Oupicky D., Ulbrich K., Seymour L.W., and Schacht E.H. Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. Biochim. Biophys. Acta 1380 (1998) 354-368
64. Trubetskoy V.S., Loomis A., Slattum P.M., Hagstrom J.E., Budker V.G., and Wolff J.A. Caged DNA does not aggregate in high ionic strength solutions. Bioconjug. Chem. 10 (1999) 624-628
65. Uster P.S., and Deamer D.W. pH-dependent fusion of liposomes using titratable polycations. Biochemistry 24 (1985) 1-8
66. Wagner E. Effects of membrane-active agents in gene delivery. J. Control. Release 53 (1998) 155-158
67. Wang C.Y., and Huang L. Polyhistidine mediates an acid-dependent fusion of negatively charged liposomes. Biochemistry 23 (1984) 4409-4416
68. Ward C.M., Acheson N., and Seymour L.W. Folic acid targeting of protein conjugates into ascites tumour cells from ovarian cancer patients. J. Drug. Target 8 (2000) 119-123
69. Ward C.M., Read M.L., and Seymour L.W. Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: Differential circulation in mice and rats and the implications for human gene therapy. Blood 97 (2001) 2221-2229
70. Wattiaux R., Laurent N., Wattiaux-De Coninck S., and Jadot M. Endosomes, lysosomes: Their implication in gene transfer. Adv. Drug. Deliv. Rev. 41 (2000) 201-208
71. Wheeler J.J., Palmer L., Ossanlou M., MacLachlan I., Graham R.W., Zhang Y.P., Hope M.J., Scherrer P., and Cullis P.R. Stabilized plasmid-lipid particles: Construction and characterization. Gene. Ther. 6 (1999) 271-278
72. Wolfert M.A., Dash P.R., Nazarova O., Oupicky D., Seymour L.W., Smart S., Strohalm J., and Ulbrich K. Polyelectrolyte vectors for gene delivery: Influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjug. Chem. 10 (1999) 993-1004
73. Wolfert M.A., Schacht E.H., Toncheva V., Ulbrich K., Nazarova O., and Seymour L.W. Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. Hum. Gene. Ther. 7 (1996) 2123-2133
74. Wolschek M.F., Thallinger C., Kursa M., Rossler V., Allen M., Lichtenberger C., Kircheis R., Lucas T., Willheim M., Reinisch W., Gangl A., Wagner E., and Jansen B. Specific systemic non-viral gene delivery to human hepatocellular carcinoma xenografts in SCID mice. Hepatology 36 (2002) 1106-1114
75. Xu Y., and Szoka Jr. F.C. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35 (1996) 5616-5623
76. Yoo G.H., Hung M.C., Lopez-Berestein G., LaFollette S., Ensley J.F., Carey M., Batson E., Reynolds T.C., and Murray J.L. Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer. Clin. Cancer Res. 7 (2001) 1237-1245
77. Zabner J., Fasbender A.J., Moninger T., Poellinger K.A., and Welsh M.J. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270 (1995) 18997-19007
78. Zanta M.A., Belguise-Valladier P., and Behr J.P. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA 96 (1999) 91-96
79. Zelphati O., Liang X., Hobart P., and Felgner P.L. Gene chemistry: Functionally and conformationally intact fluorescent plasmid DNA. Hum. Gene. Ther. 10 (1999) 15-24
80. Zhang X., Dong X., Sawyer G.J., Collins L., and Fabre J.W. Regional hydrodynamic gene delivery to the rat liver with physiological volumes of DNA solution. J. Gene. Med. 6 (2004) 693-703
81. Zhang X., Sawyer G.J., Dong X., Qiu Y., Collins L., and Fabre J.W. The in vivo use of chloroquine to promote non-viral gene delivery to the liver via the portal vein and bile duct. J. Gene. Med. 5 (2003) 209-218